<ARTICLE> 5 <LEGEND> This schedule contains summary financial information extracted from the BioCryst Pharmaceuticals, Inc. Financial Statements, and is qualified in its entirety by reference to such financial statements. </LEGEND> <PERIOD-TYPE> YEAR 3-MOS <FISCAL-YEAR-END> DEC-31-1995 DEC-31-1996 <PERIOD-START> JAN-01-1995 JAN-01-1996 <PERIOD-END> DEC-31-1995 MAR-31-1996 <CASH> 6,134,968 9,563,150 <SECURITIES> 5,279,076 7,823,942 <RECEIVABLES> 0 0 <ALLOWANCES> 0 0 <INVENTORY> 0 0 <CURRENT-ASSETS> 11,693,430 17,849,189 <PP&E> 3,065,587 3,113,489 <DEPRECIATION> 1,702,804 1,835,459 <TOTAL-ASSETS> 13,056,213 19,127,219 <CURRENT-LIABILITIES> 1,129,304 1,128,020 <BONDS> 0 0 <PREFERRED-MANDATORY> 0 0 <PREFERRED> 0 0 <COMMON> 95,043 105,198 <OTHER-SE> 11,231,455 17,369,649 <TOTAL-LIABILITY-AND-EQUITY> 13,056,213 19,127,219 <SALES> 0 0 <TOTAL-REVENUES> 222,329 21,279 <CGS> 0 0 <TOTAL-COSTS> 0 0 <OTHER-EXPENSES> 0 0 <LOSS-PROVISION> 0 0 <INTEREST-EXPENSE> 144,115 29,168 <INCOME-PRETAX> (8,576,264) (1,912,636) <INCOME-TAX> 0 0 <INCOME-CONTINUING> 0 0 <DISCONTINUED> 0 0 <EXTRAORDINARY> 0 0 <CHANGES> 0 0 <NET-INCOME> (8,576,264) (1,912,636) <EPS-PRIMARY> (0.96) (0.20) <EPS-DILUTED> (0.96) (0.20)